These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32628005)

  • 1. Improving Membrane Permeation in the Beyond Rule-of-Five Space by Using Prodrugs to Mask Hydrogen Bond Donors.
    Barlow N; Chalmers DK; Williams-Noonan BJ; Thompson PE; Norton RS
    ACS Chem Biol; 2020 Aug; 15(8):2070-2078. PubMed ID: 32628005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
    Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
    Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of the physicochemical properties of esterase-sensitive cyclic prodrugs of opioid peptides using coumarinic acid and phenylpropionic acid linkers.
    Wang B; Nimkar K; Wang W; Zhang H; Shan D; Gudmundsson O; Gangwar S; Siahaan T; Borchardt RT
    J Pept Res; 1999 Apr; 53(4):370-82. PubMed ID: 10406215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Molecular Properties, Bioavailability, and Permeability across the Bayer Compound Collection.
    O' Donovan DH; De Fusco C; Kuhnke L; Reichel A
    J Med Chem; 2023 Feb; 66(4):2347-2360. PubMed ID: 36752336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do Drug-likeness Rules Apply to Oral Prodrugs?
    Protti ÍF; Rodrigues DR; Fonseca SK; Alves RJ; de Oliveira RB; Maltarollo VG
    ChemMedChem; 2021 May; 16(9):1446-1456. PubMed ID: 33471444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
    Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
    J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses of cyclic prodrugs of RGD peptidomimetics with various macrocyclic ring sizes: evaluation of physicochemical, transport and antithrombic properties.
    He HT; Xu CR; Song X; Siahaan TJ
    J Pept Res; 2003 Jun; 61(6):331-42. PubMed ID: 12753380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of 3D properties to characterize beyond rule-of-5 property space for passive permeation.
    Guimarães CR; Mathiowetz AM; Shalaeva M; Goetz G; Liras S
    J Chem Inf Model; 2012 Apr; 52(4):882-90. PubMed ID: 22394163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of conformation on the membrane permeation of coumarinic acid- and phenylpropionic acid-based cyclic prodrugs of opioid peptides.
    Gudmundsson OS; Jois SD; Vander Velde DG; Siahaan TJ; Wang B; Borchardt RT
    J Pept Res; 1999 Apr; 53(4):383-92. PubMed ID: 10406216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of conformation of the acyloxyalkoxy-based cyclic prodrugs of opioid peptides on their membrane permeability.
    Gudmundsson OS; Vander Velde DG; Jois SD; Bak A; Siahaan TJ; Borchardt RT
    J Pept Res; 1999 Apr; 53(4):403-13. PubMed ID: 10406218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esterase-sensitive cyclic prodrugs of peptides: evaluation of a phenylpropionic acid promoiety in a model hexapeptide.
    Pauletti GM; Gangwar S; Wang B; Borchardt RT
    Pharm Res; 1997 Jan; 14(1):11-7. PubMed ID: 9034215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing oral absorption of peptides using prodrug strategies.
    Borchardt RT
    J Control Release; 1999 Nov; 62(1-2):231-8. PubMed ID: 10518655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of novel coumarin-based esterase-sensitive cyclic prodrugs of peptidomimetic RGD analogs with improved membrane permeability.
    Wang B; Wang W; Camenisch GP; Elmo J; Zhang H; Borchardt RT
    Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):90-5. PubMed ID: 9987829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen-Bond Donors in Drug Design.
    Kenny PW
    J Med Chem; 2022 Nov; 65(21):14261-14275. PubMed ID: 36282210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodrug and analog approaches to improving the intestinal absorption of a cyclic peptide, GPIIb/IIIa receptor antagonist.
    Saitoh H; Aungst BJ
    Pharm Res; 1997 Aug; 14(8):1026-9. PubMed ID: 9279884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esterase-sensitive cyclic prodrugs of peptides: evaluation of an acyloxyalkoxy promoiety in a model hexapeptide.
    Pauletti GM; Gangwar S; Okumu FW; Siahaan TJ; Stella VJ; Borchardt RT
    Pharm Res; 1996 Nov; 13(11):1615-23. PubMed ID: 8956324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylpropionic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeation.
    Gudmundsson OS; Nimkar K; Gangwar S; Siahaan T; Borchardt RT
    Pharm Res; 1999 Jan; 16(1):16-23. PubMed ID: 9950273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coumarinic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeability.
    Gudmundsson OS; Pauletti GM; Wang W; Shan D; Zhang H; Wang B; Borchardt RT
    Pharm Res; 1999 Jan; 16(1):7-15. PubMed ID: 9950272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of permeation enhancing strategies for an oral factor Xa inhibitor using the Caco-2 cell monolayer model.
    Bruesewitz C; Funke A; Kuhland U; Wagner T; Lipp R
    Eur J Pharm Biopharm; 2006 Oct; 64(2):229-37. PubMed ID: 16904877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism.
    Landowski CP; Song X; Lorenzi PL; Hilfinger JM; Amidon GL
    Pharm Res; 2005 Sep; 22(9):1510-8. PubMed ID: 16132363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.